Skip to content
10-Q

Quarterly Report

CARGO Therapeutics, Inc.

0000950170-24-125369

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 7, 2024 46.03M sh
Shares Diluted Q3 2024 · Sep 30, 2024 47.66M sh
Shares Diluted Q3 2024 · Sep 30, 2024 44.01M sh
Shares Diluted Q3 2024 · Sep 30, 2023 748.86K sh
Shares Diluted Q3 2024 · Sep 30, 2023 673.18K sh
Capex Q3 2024 · Sep 30, 2024 $3.82M
Capex Q3 2024 · Sep 30, 2023 $5.66M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$104.86M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$52.18M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $71.18M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $405.73M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $60.34M
Stockholders Equity Q3 2024 · Sep 30, 2024 $400.88M
Stockholders Equity Q3 2024 · Jun 30, 2024 $436.1M
Stockholders Equity Q3 2024 · Mar 31, 2024 $373.21M
Stockholders Equity Q3 2024 · Dec 31, 2023 $405.39M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$109.34M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$74.98M
Stockholders Equity restated Q3 2024 · Mar 31, 2023 −$57.76M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$35.24M
Current Liabilities Q3 2024 · Sep 30, 2024 $21.64M
Current Liabilities Q3 2024 · Dec 31, 2023 $21.16M
Total Liabilities Q3 2024 · Sep 30, 2024 $50.08M
Total Liabilities Q3 2024 · Dec 31, 2023 $47.65M
Current Assets Q3 2024 · Sep 30, 2024 $410.02M
Current Assets Q3 2024 · Dec 31, 2023 $409.48M
Total Assets Q3 2024 · Sep 30, 2024 $450.96M
Total Assets Q3 2024 · Dec 31, 2023 $453.04M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.88
Eps Diluted Q3 2024 · Sep 30, 2024 −$2.77
Eps Diluted Q3 2024 · Sep 30, 2023 −$47.37
Eps Diluted Q3 2024 · Sep 30, 2023 −$98.15
Eps Basic Q3 2024 · Sep 30, 2024 −$0.88
Eps Basic Q3 2024 · Sep 30, 2024 −$2.77
Eps Basic Q3 2024 · Sep 30, 2023 −$47.37
Eps Basic Q3 2024 · Sep 30, 2023 −$98.15
Sga Expense Q3 2024 · Sep 30, 2024 $11.18M
Sga Expense Q3 2024 · Sep 30, 2024 $33.34M
Sga Expense Q3 2024 · Sep 30, 2023 $6.48M
Sga Expense Q3 2024 · Sep 30, 2023 $13.03M
Rd Expense Q3 2024 · Sep 30, 2024 $35.93M
Rd Expense Q3 2024 · Sep 30, 2024 $103.89M
Rd Expense Q3 2024 · Sep 30, 2023 $22.23M
Rd Expense Q3 2024 · Sep 30, 2023 $48.72M
Net Income Q3 2024 · Sep 30, 2024 −$41.91M
Net Income Q3 2024 · Sep 30, 2024 −$122.07M
Net Income Q3 2024 · Jun 30, 2024 −$44.35M
Net Income Q3 2024 · Mar 31, 2024 −$35.81M
Net Income Q3 2024 · Sep 30, 2023 −$35.47M
Net Income Q3 2024 · Sep 30, 2023 −$66.07M
Net Income restated Q3 2024 · Jun 30, 2023 −$17.85M
Net Income restated Q3 2024 · Mar 31, 2023 −$12.75M
Operating Income Q3 2024 · Sep 30, 2024 −$47.11M
Operating Income Q3 2024 · Sep 30, 2024 −$137.24M
Operating Income Q3 2024 · Sep 30, 2023 −$28.71M
Operating Income Q3 2024 · Sep 30, 2023 −$61.75M